M&A Deal Summary

Titan Pharmaceuticals Acquires JT Pharmaceuticals - kappa opioid agonist peptide

On October 28, 2020, Titan Pharmaceuticals acquired life science company JT Pharmaceuticals - kappa opioid agonist peptide from JT Pharmaceuticals

Acquisition Highlights
  • This is Titan Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Titan Pharmaceuticals’ 1st transaction in the United States.
  • This is Titan Pharmaceuticals’ 1st transaction in South Carolina.

M&A Deal Summary
Date 2020-10-28
Target JT Pharmaceuticals - kappa opioid agonist peptide
Sector Life Science
Buyer(s) Titan Pharmaceuticals
Sellers(s) JT Pharmaceuticals
Deal Type Divestiture

Target

JT Pharmaceuticals - kappa opioid agonist peptide

Mt. Pleasant, South Carolina, United States
JT Pharmaceuticals, Inc.'s kappa opioid agonist peptide JT-09 is a provider of drug delivery technology, for the treatment of chronic pruritus. JT Pharmaceuticals's kappa opioid agonist peptide is based in Mt. Pleasant, South Carolina.

Search 200,626 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Titan Pharmaceuticals

South San Francisco, California, United States
Category Company
Founded 1992
Sector Life Science
Employees4
Revenue 1M USD (2020)
DESCRIPTION

Titan Pharmaceuticals is an operator of a commercial-stage company developing proprietary therapeutics with its ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes. Titan Pharmaceuticals was founded in 1992 and is based in South San Francisco, California.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (South Carolina) 1 of 1
Country (United States) 1 of 1
Year (2020) 1 of 1

Seller(S) 1

SELLER

JT Pharmaceuticals

Mt. Pleasant, South Carolina, United States
Category Company
Sector Life Science
DESCRIPTION

JT Pharmaceuticals, Inc. is an operator of a peptide drug development company focused on creating new drugs for acute, medically underserved, indications. JT Pharmaceuticals rapidly developing a nucleus of novel biotechnology companies and is primed for further expansion. JT Pharmaceuticals is based in Mt. Pleasant, South Carolina.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (South Carolina) 1 of 1
Country (United States) 1 of 1
Year (2020) 1 of 1
Mergr

Product

Company

Legal